Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods turns milk into gut-healthy kefir, but its SEC disclosures are where you’ll spot the numbers behind every probiotic bottle. Investors often ask where to locate milk-price sensitivity, how much revenue the ProBugs kids line contributes, or whether new distribution in the UAE affects margins. Those answers sit inside dense 10-Ks and 10-Qs—documents that can stretch past 300 pages.
Stock Titan’s AI trims the reading list. Open the Lifeway Foods quarterly earnings report 10-Q filing and our algorithm highlights same-store sales growth, inventory levels, and commodity cost hedges. Need Lifeway Foods insider trading Form 4 transactions? Real-time alerts surface every executive stock move, giving you the complete Lifeway Foods Form 4 insider transactions real-time feed without sorting through EDGAR. You’ll also find plain-language cards that make Lifeway Foods SEC filings explained simply, from Lifeway Foods annual report 10-K simplified to Lifeway Foods 8-K material events explained.
Why dig this deep? Filings reveal how Lifeway manages dairy supply contracts, tracks live-culture quality controls, and prices its expanding international lineup. In the proxy you’ll see Lifeway Foods proxy statement executive compensation that links bonuses to sales of kefir and cheese, while our dashboard delivers Lifeway Foods earnings report filing analysis that compares gut-health SKUs quarter over quarter. For advanced monitoring, set watchlists to flag Lifeway Foods executive stock transactions Form 4 before product launches. From milk procurement footnotes to distribution-channel breakdowns, our AI turns regulatory text into actionable context so you can focus on the trends—not the paperwork.
Form 144 Notice of Proposed Sale filed by Lifeway Foods director Jason Scher, indicating intent to sell 16,366 shares of common stock with an aggregate market value of $396,734.75 through Morgan Stanley Smith Barney on NASDAQ.
The securities to be sold were acquired through multiple private transactions as compensation between 2021-2023:
- 3,802 shares each on 07/15/2021, 07/15/2022, and 07/15/2023
- 2,221 shares on 06/20/2021
- 2,739 shares on 06/20/2022
Recent trading activity shows Scher has already sold 8,200 shares for total proceeds of $198,604 through five separate transactions on 06/26/2025. The filing confirms no knowledge of material adverse information regarding Lifeway Foods' operations.
Lifeway Foods director Jason Scher has filed Form 144, indicating his intention to sell 8,200 shares of common stock with an aggregate market value of $198,604 through Morgan Stanley Smith Barney LLC. The planned sale is scheduled for June 26, 2025, on the NASDAQ exchange.
The shares to be sold were acquired through multiple compensation-based private acquisitions from the issuer between 2019-2021, including:
- 1,648 shares on June 15, 2019
- 1,647 shares on June 15, 2020
- 2,740 shares on June 20, 2020
- 1,647 shares on June 15, 2021
- 518 shares on June 20, 2021
The filing indicates that Scher has not sold any company securities in the past three months and affirms no knowledge of undisclosed material adverse information regarding Lifeway Foods' operations. The company currently has 15,203,241 shares outstanding.
Lifeway Foods announced a Separation Agreement with former executive Amy Feldman on June 16, 2025. The agreement includes significant compensation and equity arrangements:
- A lump sum payment of $555,313.13, subject to statutory deductions
- Immediate vesting of 7,875 restricted stock units
- Vesting of 5,448 performance stock units under the 2022 Omnibus Incentive Plan
The agreement includes a comprehensive release of claims by Feldman and confirms that no additional compensation or benefits will be provided beyond those specified. The settlement fulfills all obligations under Feldman's original executive employment agreement from October 31, 2018. This material event follows her previously reported termination announced in March 2025.
FAQ
What is the current stock price of Lifeway Food (LWAY)?
What is the market cap of Lifeway Food (LWAY)?
What is the core business of Lifeway Foods, Inc.?
How does Lifeway differentiate its products?
Which markets does Lifeway Foods serve?
What are Lifeway Foods' flagship products?
How does Lifeway emphasize health benefits in its product lineup?
What strategies support Lifeway Foods' international expansion?
